AbCellera Biologics Company

AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.
Industry: Early Drug Development
Headquarters: Vancouver, British Columbia, Canada
Founded Date: 2012-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 12
Total Funding: 371217878
Estimated Revenue: $10M to $50M
Last Funding Date: 2020-05-27
Last Funding Type: Series B

Visit Website
Register and Claim Ownership